Nidan Labs & Healthcare

20.40
0.00
(0.00%)
Market Cap
28.40 Cr
EPS
1.42
PE Ratio
14.37
Dividend Yield
0.00 %
52 Week High
36.50
52 Week Low
16.05
PB Ratio
0.42
Debt to Equity
0.17
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
2,926.50
#1 24,542.00
50.10
#1 2,554.80
11.28
#1 492
81.24
59.16
1,020.45
10,361.60
72.73
681.39
20.11
152
3.56
61.51
1,885.30
10,229.80
67.29
1,331.20
4.59
142
-20.00
60.20
1,085.45
5,733.20
66.60
702.20
8.63
91
25.58
65.89
812.65
2,605.60
33.97
717.16
25.65
81
10.70
82.28
317.15
1,668.70
51.95
252.09
14.77
31
14.29
42.96
1,500.00
1,307.30
26.95
96.47
25.47
49
-9.09
45.27
270.90
852.20
#1 8.99
1,110.95
35.04
-197
-18.52
40.83
243.95
501.80
26.17
147.04
#1 248.07
18
#1 175.00
46.01
187.00
131.90
85.39
41.78
6.34
1
28.57
64.32
Forecast
Actual
Growth Rate
Revenue Growth
-2.54 %
Net Income Growth
-191.43 %
Cash Flow Change
-236.10 %
ROE
-195.69 %
ROCE
-102.77 %
EBITDA Margin (Avg.)
-7.03 %

Yearly Financial Results

Annual Financials
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
21
22
21
30
28
27
25
24
Expenses
13
15
12
20
18
18
19
15
EBITDA
8
8
10
10
10
9
5
9
Operating Profit %
38 %
34 %
44 %
32 %
28 %
27 %
21 %
19 %
Depreciation
3
3
3
3
3
3
2
3
Interest
5
4
4
3
2
2
2
3
Profit Before Tax
0
1
3
5
5
-2
3
4
Tax
0
0
1
2
1
1
1
1
Net Profit
0
1
2
3
4
-3
2
3
EPS in ₹
0.23
0.72
2.33
2.32
2.55
-2.33
1.42
2.90

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
Total Assets
43
45
54
89
84
83
83
Fixed Assets
23
20
20
21
21
18
17
Current Assets
19
24
23
25
21
30
11
Capital Work in Progress
0
0
0
4
0
0
0
Investments
0
0
0
0
0
0
1
Other Assets
20
25
34
64
63
65
0
Total Liabilities
43
45
54
89
84
83
83
Current Liabilities
1
-0
26
13
10
11
10
Non Current Liabilities
32
34
14
10
5
5
5
Total Equity
10
11
13
66
69
66
68
Reserve & Surplus
0
1
3
52
56
52
54
Share Capital
10
10
10
14
14
14
14

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
Net Cash Flow
4
3
-0
1
0
-6
Investing Activities
1
0
-3
-36
-0
10
Operating Activities
9
5
4
8
11
-15
Financing Activities
-6
-2
-1
29
-10
-1

Share Holding

% Holding
Oct 2021
Nov 2021
Mar 2022
Sept 2022
Mar 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Promoter
99.99 %
71.22 %
71.22 %
71.22 %
71.22 %
62.79 %
57.04 %
57.04 %
57.04 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
20.86 %
26.60 %
25.63 %
26.62 %
33.22 %
39.33 %
39.60 %
39.78 %
Others
0.01 %
7.92 %
2.18 %
3.15 %
2.16 %
3.99 %
3.64 %
3.36 %
3.18 %
No of Share Holders
15
2,940
2,791
2,516
2,440
2,777
2,864
2,790
2,581

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 18.90 21.70
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 30.50 30.00
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 33.10 32.50

Technical Indicators

RSI(14)
Neutral
47.76
ATR(14)
Less Volatile
0.64
STOCH(9,6)
Neutral
31.56
STOCH RSI(14)
Neutral
27.74
MACD(12,26)
Bearish
-0.07
ADX(14)
Weak Trend
9.02
UO(9)
Bearish
64.13
ROC(12)
Uptrend And Accelerating
2.00
WillR(14)
Neutral
-64.29